Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Politician Banned from Twitter for Claiming Men Cannot Get Pregnant

Twitter banned a Spanish politician for saying that a man…
Read more

Turkish President About Biden: He has ‘Bloody Hands’ on Israel

The President of Turkey claims that President Biden has "bloody…
Read more
Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Humanity Obligated to Confront Israeli Aggression

The Turkish President came against Israel as a "Terrorist…
Read more